DNA methylation changes in cancer

Progress in Molecular Biology and Translational Science

Volumn 101, Issue , 2011, Pages 447-457

  Toyota, Minoru ^a   Yamamoto, Eiichiro ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Carcinogenesis; Colorectal cancer; CpG island methylator phenotype; DNA methylation; Epigenetics; Gene expression; Tumor suppressor gene

Indexed keywords

EID: 79955072336     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387685-0.00014-7     Document Type: Chapter

References (62)

1. W. Reik, W. Dean, and J. Walter Epigenetic reprogramming in mammalian development Science 293 2001 1089 1093 (Pubitemid 32758081)
2. D. Takai, and P.A. Jones Comprehensive analysis of CpG islands in human chromosomes 21 and 22 Proc Natl Acad Sci USA 99 2002 3740 3745 (Pubitemid 34252176)
3. P.A. Jones, and S.B. Baylin The epigenomics of cancer Cell 128 2007 683 692 (Pubitemid 46273572)
4. P.W. Laird, L. Jackson-Grusby, A. Fazeli, S.L. Dickinson, W.E. Jung, and E. Li Suppression of intestinal neoplasia by DNA hypomethylation Cell 81 1995 197 205
5. C.A. Eads, A.E. Nickel, and P.W. Laird Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in Apc(Min/+) Dnmt1-hypomorphic mice Cancer Res 62 2002 1296 1299 (Pubitemid 34407781)
6. Y. Kanai, S. Ushijima, Y. Kondo, Y. Nakanishi, and S. Hirohashi DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers Int J Cancer 91 2001 205 212 (Pubitemid 32041741)
7. D.F. Peng, Y. Kanai, M. Sawada, S. Ushijima, N. Hiraoka, and S. Kitazawa DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas Carcinogenesis 27 2006 1160 1168 (Pubitemid 43985431)
8. H. Peng, N. Shen, L. Qian, X.L. Sun, P. Koduru, and L.O. Goodwin Hypermethylation of CpG islands in the mouse asparagine synthetase gene: relationship to asparaginase sensitivity in lymphoma cells. Partial methylation in normal cells Br J Cancer 85 2001 930 935 (Pubitemid 33010564)
9. Y. Saito, Y. Kanai, M. Sakamoto, H. Saito, H. Ishii, and S. Hirohashi Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis Hepatology 33 2001 561 568 (Pubitemid 32185217)
10. T. Nakagawa, Y. Kanai, Y. Saito, T. Kitamura, T. Kakizoe, and S. Hirohashi Increased DNA methyltransferase 1 protein expression in human transitional cell carcinoma of the bladder J Urol 170 2003 2463 2466 (Pubitemid 37414035)
11. H. Lin, Y. Yamada, S. Nguyen, H. Linhart, L. Jackson-Grusby, and A. Meissner Suppression of intestinal neoplasia by deletion of Dnmt3b Mol Cell Biol 26 2006 2976 2983
12. H.G. Linhart, H. Lin, Y. Yamada, E. Moran, E.J. Steine, and S. Gokhale Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing Genes Dev 21 2007 3110 3122 (Pubitemid 350223528)
13. I. Girault, S. Tozlu, R. Lidereau, and I. Bieche Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas Clin Cancer Res 9 2003 4415 4422 (Pubitemid 37248399)
14. R.K. Lin, H.S. Hsu, J.W. Chang, C.Y. Chen, J.T. Chen, and Y.C. Wang Alteration of DNA methyltransferases contributes to 5′CpG methylation and poor prognosis in lung cancer Lung Cancer 55 2007 205 213
15. K. Nosho, K. Shima, N. Irahara, S. Kure, Y. Baba, and G.J. Kirkner DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer Clin Cancer Res 15 2009 3663 3671
16. M.S. Samuel, H. Suzuki, M. Buchert, T.L. Putoczki, N.C. Tebbutt, and T. Lundgren-May Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling Gastroenterology 137 2009 902 913 913.e901913.e911
17. J.P. Issa, N. Ahuja, M. Toyota, M.P. Bronner, and T.A. Brentnall Accelerated age-related CpG island methylation in ulcerative colitis Cancer Res 61 2001 3573 3577 (Pubitemid 32694963)
18. T. Maekita, K. Nakazawa, M. Mihara, T. Nakajima, K. Yanaoka, and M. Iguchi High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk Clin Cancer Res 12 2006 989 995 (Pubitemid 43259882)
19. M. Kusano, M. Toyota, H. Suzuki, K. Akino, F. Aoki, and M. Fujita Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus Cancer 106 2006 1467 1479
20. L. Shen, N. Ahuja, Y. Shen, N.A. Habib, M. Toyota, and A. Rashid DNA methylation and environmental exposures in human hepatocellular carcinoma J Natl Cancer Inst 94 2002 755 761 (Pubitemid 34567960)
21. M. Esteller Epigenetics in cancer N Engl J Med 358 2008 1148 1159
22. M. Toyota, H. Suzuki, T. Yamashita, K. Hirata, K. Imai, and T. Tokino Cancer epigenomics: implications of DNA methylation in personalized cancer therapy Cancer Sci 100 2009 787 791
23. H. Suzuki, D.N. Watkins, K.W. Jair, K.E. Schuebel, S.D. Markowitz, and W.D. Chen Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer Nat Genet 36 2004 417 422 (Pubitemid 38437267)
24. J. Downward Targeting RAS signalling pathways in cancer therapy Nat Rev Cancer 3 2003 11 22 (Pubitemid 37328883)
25. H. Rajagopalan, A. Bardelli, C. Lengauer, K.W. Kinzler, B. Vogelstein, and V.E. Velculescu Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status Nature 418 2002 934 (Pubitemid 34976022)
26. K. Akino, M. Toyota, H. Suzuki, H. Mita, Y. Sasaki, and M. Ohe-Toyota The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer Gastroenterology 129 2005 156 169 (Pubitemid 41002052)
27. R. Dammann, C. Li, J.H. Yoon, P.L. Chin, S. Bates, and G.P. Pfeifer Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 Nat Genet 25 2000 315 319 (Pubitemid 30437320)
28. T. Imai, M. Toyota, H. Suzuki, K. Akino, K. Ogi, and Y. Sogabe Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma Cancer Sci 99 2008 958 966 (Pubitemid 351997598)
29. R. Maruyama, K. Akino, M. Toyota, H. Suzuki, T. Imai, and M. Ohe-Toyota Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer Carcinogenesis 29 2008 1312 1318
30. M. Hollstein, D. Sidransky, B. Vogelstein, and C.C. Harris p53 mutations in human cancers Science 253 1991 49 53 (Pubitemid 21917115)
31. H. Suzuki, F. Itoh, M. Toyota, T. Kikuchi, H. Kakiuchi, and K. Imai Inactivation of the 14-3-3 sigma gene is associated with 5′ CpG island hypermethylation in human cancers Cancer Res 60 2000 4353 4357 (Pubitemid 32103610)
32. M. Esteller, S. Tortola, M. Toyota, G. Capella, M.A. Peinado, and S.B. Baylin Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status Cancer Res 60 2000 129 133 (Pubitemid 30058742)
33. W. Qiu, B. Zhou, H. Zou, X. Liu, P.G. Chu, and R. Lopez Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma Am J Pathol 165 2004 1689 1699 (Pubitemid 39435167)
34. Y. Saito, G. Liang, G. Egger, J.M. Friedman, J.C. Chuang, and G.A. Coetzee Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells Cancer Cell 9 2006 435 443 (Pubitemid 43832188)
35. L. He, X. He, L.P. Lim, E. de Stanchina, Z. Xuan, and Y. Liang A microRNA component of the p53 tumour suppressor network Nature 447 2007 1130 1134 (Pubitemid 47014436)
36. M. Toyota, H. Suzuki, Y. Sasaki, R. Maruyama, K. Imai, and Y. Shinomura Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer Cancer Res 68 2008 4123 4132
37. K. Kozaki, I. Imoto, S. Mogi, K. Omura, and J. Inazawa Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer Cancer Res 68 2008 2094 2105 (Pubitemid 351521781)
38. J.M. Cunningham, E.R. Christensen, D.J. Tester, C.Y. Kim, P.C. Roche, and L.J. Burgart Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability Cancer Res 58 1998 3455 3460 (Pubitemid 28371090)
39. J.G. Herman, A. Umar, K. Polyak, J.R. Graff, N. Ahuja, and J.P. Issa Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma Proc Natl Acad Sci USA 95 1998 6870 6875 (Pubitemid 28278073)
40. M. Toyota, N. Ahuja, M. Ohe-Toyota, J.G. Herman, S.B. Baylin, and J.P. Issa CpG island methylator phenotype in colorectal cancer Proc Natl Acad Sci USA 96 1999 8681 8686 (Pubitemid 29354851)
41. D.J. Weisenberger, K.D. Siegmund, M. Campan, J. Young, T.I. Long, and M.A. Faasse CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer Nat Genet 38 2006 787 793 (Pubitemid 43980599)
42. T. Hinoue, D.J. Weisenberger, F. Pan, M. Campan, M. Kim, and J. Young Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling PLoS One 4 2009 e8357
43. H. Suzuki, S. Igarashi, M. Nojima, R. Maruyama, E. Yamamoto, and M. Kai IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype Carcinogenesis 31 2010 342 349
44. H. Noushmehr, D.J. Weisenberger, K. Diefes, H.S. Phillips, K. Pujara, and B.P. Berman Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma Cancer Cell 17 2010 510 522
45. F. Gaudet, J.G. Hodgson, A. Eden, L. Jackson-Grusby, J. Dausman, and J.W. Gray Induction of tumors in mice by genomic hypomethylation Science 300 2003 489 492 (Pubitemid 36444330)
46. M. Ehrlich DNA methylation in cancer: too much, but also too little Oncogene 21 2002 5400 5413 (Pubitemid 34983477)
47. A.S. Wilson, B.E. Power, and P.L. Molloy DNA hypomethylation and human diseases Biochim Biophys Acta 1775 2007 138 162 (Pubitemid 44881198)
48. A.P. Feinberg, and B. Vogelstein Hypomethylation distinguishes genes of some human cancers from their normal counterparts Nature 301 1983 89 92 (Pubitemid 13154475)
49. K. Jackson, M.C. Yu, K. Arakawa, E. Fiala, B. Youn, and H. Fiegl DNA hypomethylation is prevalent even in low-grade breast cancers Cancer Biol Ther 3 2004 1225 1231 (Pubitemid 41350957)
50. E. Yamamoto, M. Toyota, H. Suzuki, Y. Kondo, T. Sanomura, and Y. Murayama LINE-1 hypomethylation is associated with increased CpG island methylation in Helicobacter pylori-related enlarged-fold gastritis Cancer Epidemiol Biomark Prev 17 2008 2555 2564
51. R.S. Hansen, C. Wijmenga, P. Luo, A.M. Stanek, T.K. Canfield, and C.M. Weemaes The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome Proc Natl Acad Sci USA 96 1999 14412 14417 (Pubitemid 30000664)
52. M. Okano, D.W. Bell, D.A. Haber, and E. Li DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development Cell 99 1999 247 257 (Pubitemid 29519904)
53. M. Jeanpierre, C. Turleau, A. Aurias, M. Prieur, F. Ledeist, and A. Fischer An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome Hum Mol Genet 2 1993 731 735 (Pubitemid 23197518)
54. Y. Yamashita, J. Yuan, I. Suetake, H. Suzuki, Y. Ishikawa, and Y.L. Choi Array-based genomic resequencing of human leukemia Oncogene 29 2010 3723 3731
55. E.M. Wolff, H.M. Byun, H.F. Han, S. Sharma, P.W. Nichols, and K.D. Siegmund Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer PLoS Genet 6 2010 e1000917
56. H.M. Kantarjian, S. O'Brien, X. Huang, G. Garcia-Manero, F. Ravandi, and J. Cortes Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: comparison with historical experience Cancer 109 2007 1133 1137 (Pubitemid 46435392)
57. M. Duvic, R. Talpur, X. Ni, C. Zhang, P. Hazarika, and C. Kelly Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL) Blood 109 2007 31 39 (Pubitemid 46053039)
58. G. Chai, L. Li, W. Zhou, L. Wu, Y. Zhao, and D. Wang HDAC inhibitors act with 5-aza-2′-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells PLoS One 3 2008 e2445
59. A. Hurtubise, and R.L. Momparler Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-aza-2′-deoxycytidine (decitabine) on human breast carcinoma cells Cancer Chemother Pharmacol 58 2006 618 625 (Pubitemid 44167387)
60. W.G. Tong, Y. Wei, W. Stevenson, S.Q. Kuang, Z. Fang, and M. Zhang Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor Leuk Res 34 2010 221 228
61. L. Shen, H. Kantarjian, Y. Guo, E. Lin, J. Shan, and X. Huang DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes J Clin Oncol 28 2010 605 613
62. S.M. Langemeijer, R.P. Kuiper, M. Berends, R. Knops, M.G. Aslanyan, and M. Massop Acquired mutations in TET2 are common in myelodysplastic syndromes Nat Genet 41 2009 838 842